Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Sumitomo Dainippon’s Sunovion Pharmaceuticals Inc. unit said it submitted an sNDA to FDA for Aptiom eslicarbazepine acetate as monotherapy or adjunctive therapy to treat partial-onset seizures in chil...
BCIQ Company Profiles
Bial-portela & Ca. S.A.
Sumitomo Dainippon Pharma Co. Ltd.